Scarica l'app Stockscreener
1.03
6.69%
0.0646
Lexaria Bioscience Corp Azioni (LEXX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
0.00%
0.174
|
0.174 | 0.1839 | 0.084 | 0.084 |
| Cost Of Revenue |
-
|
- | 0.00272 | - | - |
| Gross Profit |
0.00%
0.174
|
0.174 | 0.1812 | 0.084 | 0.084 |
Operating Expenses
|
34.17%
3.9244
|
2.925 | 2.8719 | 2.2871 | 1.8269 |
| Benefits Costs and Expenses |
37.14%
3.9646
|
2.891 | 2.8906 | 2.2706 | 1.8683 |
| Costs And Expenses |
37.14%
3.9646
|
2.891 | 2.8906 | 2.2706 | 1.8683 |
| Depreciation and Amortization |
1,259%
0.031
|
0.00228 | 0.0332 | 0.0164 | 0.0151 |
| Operating Income/Loss |
36.33%
-3.7504
|
-2.751 | -2.6907 | -2.2031 | -1.7429 |
| Nonoperating Income/Loss |
218.05%
-0.0402
|
0.034 | -0.0159 | - | - |
| Income/Loss From Continuing Operations Before Tax |
39.52%
-3.7906
|
-2.717 | -2.7066 | -2.1866 | -1.7843 |
| Income/Loss From Continuing Operations After Tax |
39.52%
-3.7906
|
-2.717 | -2.7066 | -2.1866 | -1.7843 |
|
Net Income/Loss
|
39.52%
-3.7906
|
-2.717 | -2.7066 | -2.1866 | -1.7843 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
59.73%
-0.00151
|
-0.00376 | -0.00293 | -0.00178 | -0.00262 |
| Diluted Average Shares |
4.49%
18.30
|
17.51 | 16.67 | - | - |
| Diluted Earnings Per Share |
40.00%
-0.21
|
-0.15 | -0.16 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):